Merck & Co (MRK)
$84.68 0.00 (0.00%)
19:20 EDT MRK Stock Quote Delayed 15 Minutes
Previous Close $84.68
Market Cap 227.81B
PE Ratio 146.00
Volume (Avg. Vol.)
Day's Range 84.68 - 84.68
52-Week Range 66.10 - 87.35
Dividend & Yield 1.92 (2.27%)
MRK Stock Predictions, Articles, and Merck & Co News
- From InvestorPlace
- From the Web
With FDA Breakthrough Therapy designations and robust drug pipelines, these biotech companies are all stocks to buy for 2020.
There's a lot in the news this week, from talks of an impeachment to a potential trade war resolution. Buy these healthcare stocks to benefit.
Based on data from Equilar 200, here are 10 companies using stock buybacks to make their CEOs rich. This list names stocks like ORCL and JPM.
The stock charts of MSFT, FB and MRK have earned a closer technical look as the new trading week kicks off.
Bristol-Myers Squibb stock touched a multi-year low last month. But the BMY stock price is cheap enough now to take on real risks.
Here we looked for five of the Street’s highest-rated Dow Jones stocks right now. As you will see all five of these stocks show a firm ‘Strong Buy’ Street consensus. That's based on all the ratings received by each stock over the last three months.
Investors turned sour on BMY stock after the Celgene buyout. Will a solid Q2 earnings report change the sentiment for the better?
Options trading was buzzing in Bed Bath & Beyond, CVS, and Merck on Thursday. Here are the metrics that matter moving forward.
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
Drug stocks are falling on fears of President Trump's next move on drug prices. Here's a look at the charts.
As has been noted in this space, market participants are pricing in the following Fed facts: no interest rate cut this month and no cuts totaling 50 basis points this year. Hope burns eternal for a rate reduction of 25 basis points, but Powell's two-day testimony and the June meeting minutes could indicate otherwise.
Despite all the fear around prescription drug prices, there are some excellent healthcare stocks to buy for interested investors.
Play a friendly and widening price spread in biotech stocks with a well-place purchase in Merck and an equally smart short in AbbVie.
Investors are punishing Bristol-Myers on the markets more than they should. BMY stock's acquisition of Celgene isn't the only reason.
Smaller-capitalization biotechs can be riskier investments, but EXEL stock has more than just promise off and on the price chart and is readying to be purchased.
Analysts Offer Insights on Healthcare Companies: Merck & Company (NYSE: MRK) and Aerie Pharma (NASDAQ: AERI)
From Analyst Ratings
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Merck & Company (MRK – Research Report) and Aerie Pharma (AERI – Research Report) with bullish sentiments. Merck & Company (MRK) In a report released today, Mara Goldstein from Mizuho Securities maintained a Buy rating on Merck
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!